A Win For Acasti Pharma Inc.
Mon, Sep 21, 2020 at 05:30 PM
Acasti Pharma Inc. (ACST:NASDAQ) shot up at $0.28, representing a gain of 29%. On Fri 18 Sep 20, ACST:NASDAQ touched a New 2-Week High of $0.22. The stock appeared on our News Catalysts scanner on Mon 31 Aug 20 at 07:14 AM in the 'BIOTECH' category. From Fri 04 Sep 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon 03 Aug 20 at $0.83 with a volume of 8M+, and its share price has been moving sideways in recent weeks.
About Acasti Pharma Inc. (ACST:NASDAQ)
Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 42.86%
- Cubic Corporation (CUB:NYSE), 34.23%
- CRDF (CRDF:NASDAQ), 33.18%
- Acasti Pharma Inc. (ACST:NASDAQ), 28.99%
- CorMedix Inc. (CRMD:NYSEMKT), 24.08%
- Roku, Inc. (ROKU:NASDAQ), 17.67%
- MicroVision, Inc. (MVIS:NASDAQ), 16.38%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 16.05%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 15.57%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 15.29%